Paluchowska M H, Dereń-Wesołek A, Mokrosz J L, Charakchieva-Minol S, Chojnacka-Wójcik E
Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Arch Pharm (Weinheim). 1996 Oct;329(10):451-6. doi: 10.1002/ardp.19963291006.
Two series of new MP 3022 analogs, i.e. 1-(o-methoxyphenyl)-4-n-propylpiperazines (3, 4a, 4b, 6-9, and 12-13) and 2-(n-propyl)-1,2,3,4-tetrahydroisoquinolines (5a, 5b, 11a, and 11b) containing a terminal heteroaromatic system with a different number of nitrogen atoms, were synthesized and their 5-HT1A/5-HT2A and alpha 1 receptor affinity was assayed. The majority of investigated piperazines may be classified as non-selective 5-HT1A/5-HT2A/alpha 1 receptor ligands. Compounds 3, 4a, 4b, 7-9a with the highest affinity for 5-HT1A receptors (Ki = 4-54 nM) were tested in vivo. Their functional activity was differentiated; while 3, 8, and 9a behaved like weak antagonists of postsynaptic 5-HT1A receptors, 4b and 7 may be classified as potential partial 5-HT1A receptors, agonists. Isomer 4a has characteristic features of a potential weak postsynaptic 5-HT1A receptor agonist.
合成了两个系列的新型MP 3022类似物,即1-(邻甲氧基苯基)-4-正丙基哌嗪(3、4a、4b、6 - 9和12 - 13)以及含有不同氮原子数目的末端杂芳族体系的2-(正丙基)-1,2,3,4-四氢异喹啉(5a、5b、11a和11b),并测定了它们对5-HT1A/5-HT2A和α1受体的亲和力。大多数被研究的哌嗪可归类为非选择性5-HT1A/5-HT2A/α1受体配体。对5-HT1A受体具有最高亲和力(Ki = 4 - 54 nM)的化合物3、4a、4b、7 - 9a进行了体内测试。它们的功能活性有所不同;虽然3、8和9a表现为突触后5-HT1A受体的弱拮抗剂,但4b和7可归类为潜在的5-HT1A受体部分激动剂。异构体4a具有潜在弱突触后5-HT1A受体激动剂的特征。